Company Insights

NRC customer relationships

Explore interactive graphBrowse insights index
NRC customer relationship map

National Research Corporation (NRC): Customer Relationships Drive Predictable, Subscription-Heavy Revenue

National Research Corporation (NRC) sells subscription software and services that measure and improve patient and employee experience for healthcare providers in the U.S. and Canada. The company monetizes primarily through annually renewable, fixed-price subscription agreements for analytics, survey administration (including CAHPS), service recovery and reputation management; that recurring revenue base is supported by a meaningful backlog of contract revenue recognized over multiple years. For investors, NRC’s customer relationships combine high renewal cadence, exposure to large health systems, and a product set that is mission-critical for reimbursement and quality reporting, producing predictable cash flows with concentrated operational levers. Explore detailed customer profiles and signals at NullExposure.

How NRC’s operating model translates into cash flow

NRC is a services-oriented SaaS-like business in healthcare information services: subscription pricing for measurement and analytics, delivered as a suite of services and tools, with a strong emphasis on healthcare regulatory reporting (CAHPS) and actionable real‑time feedback. Financially, that model produces steady top-line recognition and a sizeable backlog: trailing twelve‑month revenue of $137.4M, EBITDA of $37.0M, and a market capitalization near $396M, highlighting a profitable, mid‑market enterprise with above-average margins for the sector.

Two structural characteristics drive investor outcomes:

  • High renewal rates and annual contract cadence mean revenue visibility is concentrated year-to-year but predictable; revenue-per-customer is driven by cross-sell across patient experience, employee engagement, and reputation services.
  • Customer composition skews toward large healthcare systems—over 250 of the top 400 health systems use NRC solutions—so client relationships are both valuable and sticky given the operational importance of NRC’s services to quality reporting and patient satisfaction metrics.

For a direct look at included customer relationships and signals, visit NullExposure.

What contract signals tell you about customer posture and risk

Read together, company disclosures establish a clear contracting posture and maturity profile for NRC’s customer base:

  • Subscription-dominant, annually renewable agreements. NRC states it derives a majority of revenue from annually renewable subscription-based service agreements and that its solutions are offered primarily through fixed-price subscriptions—a business model that favors recurring revenue growth and predictable churn patterns.
  • Material multi-year backlog with staged recognition. NRC reported remaining contract revenue approximating $109.5 million at December 31, 2024, with scheduled recognition of $41.6M in 2025, $38.3M in 2026, $25.1M in 2027, $2.9M in 2028 and $1.6M in 2029, indicating multi-year visibility into revenue tied to existing contracts.
  • Contract flexibility on some short-term agreements. Some agreements are cancelable on short or no notice without penalty, signalling that while the core book is recurring, parts of the portfolio retain transactional churn risk.
  • Large-enterprise concentration. The customer base includes more than 250 of the top 400 U.S. health systems by net patient revenue, confirming client scale and mission-critical usage for many relationships.
  • Geographic concentration in North America. Revenue is primarily U.S.-derived, which focuses regulatory and market risk within North America.
  • Service-provider role and renewing lifecycle. NRC acts as a provider of analytics and experience-management services; the majority of contracts are renewable annually at the client’s option, implying ongoing account management and renewal economics are central to growth.
  • Product maturity: services-led with steady adoption. The portfolio targets well-established needs—patient experience, CAHPS reporting, employee engagement—indicating a mature solution set with incremental upsell opportunities.

These constraints together present a company-level signal: NRC delivers predictable subscription revenue with multi-year visibility, yet retains pockets of short-notice cancellation risk that require active account management.

Single-client spotlight: Lake Crossing Health Center

Lake Crossing Health Center in Appling received NRC’s My InnerView “Excellence in Action” award for scoring in the top 10 percent of My InnerView customers for resident or employee satisfaction—an endorsement of NRC’s product efficacy in post‑acute care. This recognition was reported by the Augusta Chronicle in September 2016 (local news coverage of the award highlighted the client’s performance with NRC’s My InnerView product). (Augusta Chronicle, September 2016 — https://www.augustachronicle.com/story/news/local/columbia-county-news-times/2016/09/11/lake-crossing-earns-national-award/14171918007/)

Why these customer relationships matter to investors

  • Revenue visibility and valuation support. The sizable remaining contract revenue of $109.5M implies near-term revenue protection that justifies NRC’s premium multiples relative to pure-play services firms. NRC’s EV/Revenue of ~3.43 and EV/EBITDA of ~15.6 reflect expectation of sustained recurring margins.
  • Concentration elevates both opportunity and risk. Having many large health systems as clients increases LTV and cross-sell potential; however, the existence of short‑cancel clauses in parts of the book and annual renewal options means revenue can compress quickly if performance or pricing negotiations deteriorate.
  • Regulatory and operational stickiness. CAHPS and quality reporting create functional lock-in: switching vendors for mandated survey and reporting processes imposes implementation costs on customers and strengthens NRC’s retention if performance is acceptable.
  • Geographic concentration is a double-edged sword. Focus on North America simplifies go‑to‑market and regulatory alignment but concentrates exposure to U.S. healthcare funding and policy cycles.

For a closer read on customer-level signals and to monitor renewal posture across NRC’s book, check analyses at NullExposure.

Tactical takeaways and investment considerations

  • Monitor renewal rates and margin expansion. Given the annually renewable structure, quarter-to-quarter revenue trends and churn announcements will be leading indicators for valuation re-rating.
  • Watch backlog recognition and pricing dynamics. The scheduled recognition of the $109.5M backlog through 2029 provides measurable forward revenue; material deviations from expected recognition or sustained discounting on renewals would be material.
  • Assess account-level concentration. Large‑enterprise customers underpin NRC’s economics; investor due diligence should evaluate top-client retention metrics and the presence of any single‑client revenue concentration that could drive outsized volatility.

Bottom line: predictable base, active account work

NRC combines a subscription-heavy revenue base, meaningful multi-year backlog, and deep penetration among large U.S. health systems, which together produce predictable cash flows and sensible valuation support. That predictability depends on disciplined account management and successful renewals to counterbalance the portions of the book that are cancelable on short notice. For investors and operators who value stable growth with operational levers around renewals and cross-sell, NRC’s customer relationships present both clear strengths and manageable execution risks.

For ongoing tracking of NRC customer relationships and real-time signals, visit NullExposure.